Comparison of two preemptive treatment strategies of panitumumab mediated skin toxicity and assessment of quality of life in patients with Ras-wildtype colorectal cancer

Update Il y a 4 ans
Reference: EUCTR2010-022938-85

Woman and Man

  • | Country :
  • -
  • | organs :
  • -
  • | Specialty :
  • -

Extract

Percentage of patients developing no skin toxicity ≥ grade 2 at any time during their first 8-weeks of treatment with panitumumab


Inclusion criteria

  • Panitumumab-mediated Skin toxicity in palliative treatment of Metastatic colorectal cancer with panitumumab

Links